The FDA cited insufficient evidence of effectiveness for relacorilant in patients with Cushing syndrome and hypertension, ...
Wedbush Securities analyst Dan Ives, known for his colorful attire and ultra-positive coverage of tech stocks, has ranked his ...
A few years ago, Charles Schwab weathered a storm over its sweep accounts and came through the other side. Its stock now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback